av/g1-therapeutics--big.svg

NASDAQ:GTHX

G1 Therapeutics, Inc.

  • Stock

7.16

+0.14%

0.01

USD last updated 13/08 01:59:42

Last Close

7.15

17/09 19:56

Market Cap

145.87M

Beta: 1.92

Volume Today

1.10M

Avg: 1.22M

PE Ratio

−3.00

PFCF: −4.05

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or t...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.20.22017-05-232019-02-282021-02-242023-03-012024-08-07

    Revenue (Estimate*)

    10M20M30M40M2017-05-232019-02-282021-02-242023-03-012024-08-07

    *Estimate based on analyst consensus